The US Government Accountability Office has testified to the US Senate's subcommittee on Federal Financial Management, Government Information, and International Security (which is part of the Senate's Committee of Homeland Security and Government Affairs) about the Centers for Medicare and Medicaid Services' (CMS) measures to establish a new body called the Medicaid Integrity Program.
The purpose of the MIP is to control fraud and abuse in the amount of payments for Medicaid-related benefits. The GAO found that the number of staff allocated to this problem in the fiscal year 2004 was inadequate, compared with the scale of the task. Fewer than nine full-time staff were deployed to assist the 50 US states on scrutinizing $168.0 billion in payments, the subcommittee heard.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze